Luling Wu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial.

Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial.

Journal: Infectious diseases and therapy

Published: August 24, 2025

Predictive survival modelings for HIV-related cryptococcosis: comparing machine learning approaches.

Predictive survival modelings for HIV-related cryptococcosis: comparing machine learning approaches.

Journal: Frontiers in cellular and infection microbiology

Published: December 10, 2024

Correction: Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system.

Correction: Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system.

Journal: Infection

Published: May 17, 2024

Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a "shock and kill" strategy for ART-free virological control: a phase II single-arm study.

Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a "shock and kill" strategy for ART-free virological control: a phase II single-arm study.

Journal: Signal transduction and targeted therapy

Published: December 08, 2023

Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system.

Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system.

Journal: Infection

Published: November 16, 2023

Clinical Characteristics of Chlamydia psittaci Infection Diagnosed by Metagenomic Next-Generation Sequencing: A Retrospective Multi-Center Study in Fujian, China.

Clinical Characteristics of Chlamydia psittaci Infection Diagnosed by Metagenomic Next-Generation Sequencing: A Retrospective Multi-Center Study in Fujian, China.

Journal: Infection and drug resistance

Published: October 10, 2023

Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.

Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.

Journal: Archives of osteoporosis

Published: September 27, 2023

Antiretroviral therapy-naïve people living with HIV tend to have more severe symptoms of COVID-19.

Antiretroviral therapy-naïve people living with HIV tend to have more severe symptoms of COVID-19.

Journal: Chinese medical journal

Published: August 02, 2023

Use of programmed cell death protein 1 (PD-1) inhibitor therapy in HIV-infected patients with advanced cancer: a single-center study from China.

Use of programmed cell death protein 1 (PD-1) inhibitor therapy in HIV-infected patients with advanced cancer: a single-center study from China.

Journal: Infectious agents and cancer

Published: January 13, 2023

A DPA-based highly selective and sensitive fluorescent probe for mercuric ions and its imaging in living cells.

A DPA-based highly selective and sensitive fluorescent probe for mercuric ions and its imaging in living cells.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: May 26, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026